Skip to main content
Toggle navigation
Login
Home
Session Icons
Special Event
Livestream / Recorded
Multiple Session Occurences
Audience Response System
Ticketed Session
Presentado en Espanol
Closed Captioning
Scientific Program
Sold Out Ticketed Session
New & Evolving Topics
Traduccion Espanol
Rx (Pharmacology)
Poster Icons
Oral Presentations
Poster Presentations
Back
Favorite
Changming Xia, n/a
Associate Director, Statistics
Regeneron Pharmaceuticals, Inc.
Abstract(s):
P4.A004: Dupilumab Reduces Corticosteroid Use in Children With Uncontrolled Moderate-to-Severe Asthma Regardless of Exacerbation History
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT
P4.A005: Efficacy of Dupilumab by Baseline Disease Severity in Children Aged 6 to 11 Years With Uncontrolled Moderate-to-Severe Asthma: Post Hoc Results From the Randomized, Placebo-Controlled VOYAGE Trial
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT